This topic contains a solution. Click here to go to the answer

Author Question: Total lung capacity is a result of: a. vital capacity plus residual volume. b. inspiratory ... (Read 145 times)

Chelseaamend

  • Hero Member
  • *****
  • Posts: 545
Total lung capacity is a result of:
 
  a. vital capacity plus residual volume.
  b. inspiratory capacity plus residual volume.
  c. inspiratory capacity plus expiratory resid-ual volume.
  d. inspiratory reserve volume plus functional residual capacity.

Question 2

Expiratory residual volume plus residual volume equals:
 
  a. functional residual capacity. c. total lung capacity.
  b. inspiratory capacity. d. vital capacity.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

quynhmickitran

  • Sr. Member
  • ****
  • Posts: 330
Answer to Question 1

ANS: A
The total lung capacity is the sum of the vital capacity and the residual volume.

Answer to Question 2

ANS: A
Expiratory residual volume plus residual volume equals functional residual capacity.




Chelseaamend

  • Member
  • Posts: 545
Reply 2 on: Jul 16, 2018
Wow, this really help


nguyenhoanhat

  • Member
  • Posts: 332
Reply 3 on: Yesterday
Gracias!

 

Did you know?

In 2006, a generic antinausea drug named ondansetron was approved. It is used to stop nausea and vomiting associated with surgery, chemotherapy, and radiation therapy.

Did you know?

The shortest mature adult human of whom there is independent evidence was Gul Mohammed in India. In 1990, he was measured in New Delhi and stood 22.5 inches tall.

Did you know?

Bacteria have been found alive in a lake buried one half mile under ice in Antarctica.

Did you know?

To prove that stomach ulcers were caused by bacteria and not by stress, a researcher consumed an entire laboratory beaker full of bacterial culture. After this, he did indeed develop stomach ulcers, and won the Nobel Prize for his discovery.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library